Evidence map›Paper›PMID 16382182›Full record

ArticleMolecular biotechnology2006

Site-specific DNA excision in transgenic rice with a cell-permeable cre recombinase.

Ming-Xia Cao, Jian-Qiu Huang, Quan-Hong Yao, Sheng-Jun Liu, Cheng-Long Wang, Zhi-Ming Wei

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ming-Xia CaoNational Laboratory of Plant Molecular Genetics, Institute of Plant Physiology and Ecology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, People's Republic of China.
Jian-Qiu Huang
Quan-Hong Yao
Sheng-Jun Liu
Cheng-Long Wang
Zhi-Ming Wei
Chinese Academy of Sciences · CNCenter for Excellence in Molecular Plant Sciences · CNShanghai Academy of Agricultural Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The removal of selected marker genes from transgenic plants is necessary to address biosafety concerns and to carry out further experiments with transgenic organisms. In the present study, the 12-amino-acid membrane translocation sequence (MTS) from the Kaposi fibroblast growth factor (FGF)-4 was used as a carrier to deliver enzymatically active Cre proteins into living plant cells, and to produce a site-specific DNA excision in transgenic rice plants. The process, which made cells permeable to Cre recombinase-mediated DNA recombination, circumvented the need to express Cre under spatiotemporal control and was proved to be a simple and efficient system to achieve marker-free transgenic plants. The ultimate aim of the present study is to develop commercial rice cultivars free from selected marker genes to hasten public acceptance of transgenic crops.

Indexed as

Gene DeletionBlotting, SouthernCells, CulturedCinnamatesDNA, PlantEscherichia coliFibroblast Growth Factor 4Gene ExpressionGenetic EngineeringGenetic VectorsGlucuronidaseHygromycin BIntegrasesMutagenesis, Site-DirectedNuclear Localization SignalsOryzaCinnamatesCre recombinaseDNA, PlantFibroblast Growth Factor 4Glucuronidasehygromycin AHygromycin Bhygromycin-B kinaseIntegrasesNuclear Localization SignalsPhosphotransferases (Alcohol Group Acceptor)Protein Sorting SignalsRecombinant Fusion ProteinsViral Proteins

Identifiers

PMID16382182
OpenAlexW1971002874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.